Allogeneic Stem Cell Transplant Recipient
3 clinical trials · Condition
◉ Watch Allogeneic Stem Cell Transplant Recipient
| Record | Firm | Date |
|---|---|---|
| Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies (NCT07214688) | Hackensack Meridian Health | 2026-01-06 |
| Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation (NCT04127721) | M.D. Anderson Cancer Center | 2020-09-22 |
| Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML (NCT04220684) | Sumithira Vasu | 2020-06-11 |
Track Allogeneic Stem Cell Transplant Recipient automatically
Every clearance here is in the API, with alerts when new ones post.